Edition:
United States

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

29.54USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$29.54
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
256,542
52-wk High
$73.90
52-wk Low
$18.66

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.56 -1.070
Jun '18 1.09 -0.819
Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 2.66 11.30 0.50 4.15
Quarter Ending Mar-19 5 2.30 5.00 0.00 --
Year Ending Dec-18 8 5.59 14.30 4.00 13.05
Year Ending Dec-19 9 16.90 91.10 0.00 29.68
Earnings (per share)
Quarter Ending Dec-18 9 -0.77 -0.57 -0.89 -0.93
Quarter Ending Mar-19 5 -0.86 -0.80 -0.94 --
Year Ending Dec-18 9 -3.23 -2.73 -3.41 -3.01
Year Ending Dec-19 10 -3.49 -1.86 -4.63 -3.03
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 76.97 49.54 6.22
Price to Book (MRQ) 3.91 10.17 5.20
Price to Tangible Book (MRQ) 3.97 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 41.85 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 350.57 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago 570.49 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -29.58 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago 93.32 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 17.79 3.43 3.10
LT Debt to Equity (MRQ) 0.00 18.73 11.49
Total Debt to Equity (MRQ) 0.00 31.43 16.03
Interest Coverage (TTM) -5.27 -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -784.99 -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -805.36 -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -396.50 -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -406.62 -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 109,441 7,652,294 873,073,486
Net Income/Employee (TTM) -445,011 652,908 103,486,338
Receivable Turnover (TTM) 2.49 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.03 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.84 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -16.50 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -56.05 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.99 -0.56 99 98
13 Week 21.54 15.62 99 94
26 Week 0.05 -7.55 99 98
52 Week -- -- -- 68
YTD -4.74 -16.34 81 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 48.09%
# of Holders: 224
Total Shares Held: 24,956,915
3 Mo. Net Change: 5,608,190
# New Positions: 48
# Closed Positions: 48
# Increased Positions: 108
# Reduced Positions: 98
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.